Perspective Announces Presentation Of Early Clinical Data For VMT-α-NET At The 36th Annual Congress Of The European Association Of Nuclear Medicine
Portfolio Pulse from Benzinga Newsdesk
Perspective has announced the presentation of early clinical data for VMT-α-NET at the 36th Annual Congress of the European Association of Nuclear Medicine. Ten patients received therapy, with an initial response seen in 7 out of 9 evaluable patients to date. Responses were observed in both peptide receptor radionuclide therapy-naïve and peptide receptor radionuclide therapy-refractory disease.
September 12, 2023 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Perspective's announcement of early clinical data for VMT-α-NET may impact CATX, if there is a connection between the two. However, the article does not provide any specific details about CATX's involvement.
The article mentions Perspective's early clinical data for VMT-α-NET but does not provide any specific details about CATX's involvement. Therefore, it's unclear how this news might impact CATX.
CONFIDENCE 50
IMPORTANCE 0
RELEVANCE 0